home / stock / rain / rain news


RAIN News and Press, Rain Therapeutics Inc.

Stock Information

Company Name: Rain Therapeutics Inc.
Stock Symbol: RAIN
Market: NASDAQ
Website: rainthera.com

Menu

RAIN RAIN Quote RAIN Short RAIN News RAIN Articles RAIN Message Board
Get RAIN Alerts

News, Short Squeeze, Breakout and More Instantly...

RAIN - Expected US Company Earnings on Thursday, March 14th, 2024

AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...

RAIN - Pathos AI Completes Acquisition of Rain Oncology

Rain Stockholders to Receive $1.16 Per Share in Cash Plus Contingent Value Rights Pathos AI, Inc. (“Pathos”) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (“Merger Sub”), successfully completed its tender offer to acquire ...

RAIN - Rain Oncology to be acquired by Pathos AI for $1.16 in cash per share

2023-12-14 00:41:21 ET More on Rain Oncology Rain Oncology gets $1.25/share takeover offer from Tang Capital, stock +8% after hours Seeking Alpha’s Quant Rating on Rain Oncology Historical earnings data for Rain Oncology Financial information for Rain ...

RAIN - Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights

NEWARK, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos”) will acquire Rain for $1.16 in cash per share plus a non-tradeable conting...

RAIN - Rain Oncology GAAP EPS of -$0.19 beats by $0.06

2023-11-09 17:40:19 ET Rain Oncology press release ( NASDAQ: RAIN ): Q3 GAAP EPS of -$0.19 beats by $0.06 . As of September 30, 2023, Rain had $77.3 million in cash, cash equivalents and short-term investments. For further details see: Rain Oncology GAAP EPS ...

RAIN - Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

NEWARK, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NasdaqGS: RAIN) (Rain) today reported financial results for the third quarter ended September 30, 2023, along with an update on the Company’s key developments and business operations. “Rain continues to eval...

RAIN - Expected US Company Earnings on Thursday, November 9th, 2023

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

RAIN - Expected earnings - Rain Oncology Inc.

Rain Oncology Inc. (RAIN) is expected to report $-0.27 for Q3 2023

RAIN - 3 Top Penny Stocks to Buy According To Insiders In October

2023-10-16 10:35:20 ET Finding Penny Stocks through Insider Trading Activity Penny stocks, defined as stocks trading under $5 per share, offer traders huge upside potential but also carry significant risks. One strategy used by some investors to identify promising penny stocks i...

RAIN - Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences

NEWARK, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Rain Oncology, Inc. (NasdaqGS: RAIN) (“Rain”) confirmed that it has received an unsolicited proposal from Tang Capital, LP on behalf of Concentra Biosciences LLC to acquire all outstanding shares of common stock of Rain for $1.25 per...

Next 10